Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Biochemical Journal

• Publication date

  2001-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/BJ3570107PMID 11415441PMCID PMC1221933
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.

  2000cited by this paper
• Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors.

  1999cited by this paper
• How the protease thrombin talks to cells.

  1999cited by this paper
• Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.

  1999cited by this paper
• Thrombin rapidly and efficiently activates gelatinase A in human microvascular endothelial cells via a mechanism independent of active MT1 matrix metalloproteinase.

  1999cited by this paper
• Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands.

  1999cited by this paper
• Furin-independent Pathway of Membrane Type 1-Matrix Metalloproteinase Activation in Rabbit Dermal Fibroblasts*

  1999cited by this paper
• The Human Proteinase-activated Receptor-3 (PAR-3) Gene

  1998cited by this paper
• mRNA Levels of Membrane-type 1 Matrix Metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their Inhibitors TIMP-2 and TIMP-3 in Normal Thyrocytes and Thyroid Carcinoma Cell Lines

  1998cited by this paper
• Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.

  1998cited by this paper
• Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins.

  1998cited by this paper
• Protein tyrosine phosphorylation in signalling pathways leading to the activation of gelatinase A: activation of gelatinase A by treatment with the protein tyrosine phosphatase inhibitor sodium orthovanadate.

  1998cited by this paper
• Vascular endothelial groth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatininase a activation and cell proliferation

  1998cited by this paper
• Endothelium‐dependent contractile actions of proteinase‐activated receptor‐2‐activating peptides in human umbilical vein: release of a contracting factor via a novel receptor

  1998cited by this paper
• Activation of MMP‐2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent

  1998cited by this paper
• Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells.

  1997cited by this paper
• Release of gelatinase A during platelet activation mediates aggregation

  1997cited by this paper
• Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases.

  1997cited by this paper
• Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA.

  1997cited by this paper
• Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo.

  1997cited by this paper
• Involvement of PA/plasmin system in the processing of pro‐MMP‐9 and in the second step of pro‐MMP‐2 activation

  1997cited by this paper
• Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase.

  1996cited by this paper
• Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.

  1996cited by this paper
• The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation

  1996cited by this paper
• Matrix metalloproteinases and the development of cancer.

  1996cited by this paper
• Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase

  1995cited by this paper
• Intermolecular Autolytic Cleavage Can Contribute to the Activation of Progelatinase A by Cell Membranes (*)

  1995cited by this paper
• Thrombin Induces the Activation of Progelatinase A in Vascular Endothelial Cells

  1995cited by this paper
• Plasma membrane‐dependent activation of gelatinase A in human vascular endothelial cells

  1995cited by this paper
• Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway.

  1994cited by this paper
• Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method.

  1994cited by this paper
• Distinct receptors and signaling pathways in alpha-thrombin- and thrombin receptor peptide-induced vascular contractions.

  1994cited by this paper
• Thrombin promotes angiogenesis by a mechanism independent of fibrin formation.

  1993cited by this paper
• Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

  1991cited by this paper
• Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.

  1990cited by this paper
• How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture.

  1986cited by this paper
• Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis.

  1986cited by this paper
• Pharmacology of hirudin: one hundred years after the first report of the anticoagulant agent in medicinal leeches.

  1985cited by this paper

• Endothelial protease-activated receptor 4: impotent or important?

  2025cites this paper
• The Role of Olive Oil in Cardiometabolic Risk

  2025cites this paper
• PAR1 Is a Candidate Target for the Treatment of Peritoneal Dissemination in Gastric Cancer

  2024influential citation
• New Insights into the Exosome-Induced Migration of Uveal Melanoma Cells and the Pre-Metastatic Niche Formation in the Liver

  2024cites this paper
• Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis

  2020cites this paper
• Pathologies of matrix metalloproteinase-2 underactivity: a perspective on a neglected condition 1.

  2019cites this paper
• Draft Pathologies of MMP-2 underactivity : A perspective on a neglected condition

  2018cites this paper
• Targeting the MMP-14/MMP-2/integrin αvβ3 axis with multispecific N-TIMP2–based antagonists for cancer therapy

  2018cites this paper
• Fucus vesiculosus extract inhibits the proteolytic activity and gene expression of matrix metalloproteinases in Atlantic salmon (Salmo salar L.)

  2017cites this paper
• The mechanism of action of the scorpion toxin, chlorotoxin, a bioinformatics approach

  2017cites this paper
• Selective small-molecule inhibitors as chemical tools to define the roles of matrix metalloproteinases in disease.

  2017cites this paper
• F16357, a novel protease‐activated receptor 1 antagonist, improves urodynamic parameters in a rat model of interstitial cystitis

  2016cites this paper
• Matrix metalloproteinase 14 modulates signal transduction and angiogenesis in the cornea.

  2016cites this paper
• signaling pathways'' proliferation in astrocytes via MAPK involves multiple Focus on ''Thrombin (PAR-1)-induced astrocyte function. PARs in the stars: proteinase-activated receptors and

  2016cites this paper
• implications for airway smooth muscle migration MMP-14-dependent and -independent pathways: Collagen I and thrombin activate MMP-2 by

  2016cites this paper
• Regulation and involvement of matrix metalloproteinases in vascular diseases.

  2016cites this paper
• New perspectives on bioactivity of olive oil: evidence from animal models, human interventions and the use of urinary proteomic biomarkers

  2015cites this paper
• Zebrafish scales in bone research

  2014cites this paper
• Metalloproteinases and metalloproteinase inhibitors in age-related diseases.

  2014influential citation
• Intracellular Mechanisms Responsible for Trypsin-induced Increase in Transepithelial Resistance in Intestinal Epithelial Cells

  2013cites this paper
• Hemostasis and Alterations of the Central Nervous System

  2013cites this paper
• Thrombin weakens the amnion extracellular matrix (ECM) directly rather than through protease activated receptors.

  2013cites this paper
• Metabolism Studies In Vitro and In Vivo

  2013cites this paper
• Weakening and Rupture of Human Fetal Membranes – Biochemistry and Biomechanics

  2012cites this paper
• Preterm Birth - Mother and Child

  2012cites this paper
• Dimerization of Matrix Metalloproteinase-2 (MMP-2)

  2012cites this paper
• The gelatinases and their inhibitors: the structure-activity relationships.

  2012cites this paper
• Matrix metalloproteinase inhibition therapy for vascular diseases.

  2012cites this paper
• The multiple layers of signaling selectivity at protease-activated receptors.

  2012cites this paper
• The effects of thrombin and cytokines upon the biomechanics and remodeling of isolated amnion membrane, in vitro.

  2011cites this paper
• Matrix metalloproteinases in osteoclasts of ontogenetic and regenerating zebrafish scales.

  2011cites this paper
• Microarray and Proteomic Analysis of Breast Cancer Cell and Osteoblast Co-cultures

  2011cites this paper
• Metaloproteinazy w miażdżycy naczyń krwionośnych Matrix metalloproteinases and atherosclerosis

  2011cites this paper
• [Matrix metalloproteinases and atherosclerosis].

  2011cites this paper
• Extracellular Heat Shock Protein (Hsp)70 and Hsp90α Assist in Matrix Metalloproteinase-2 Activation and Breast Cancer Cell Migration and Invasion

  2011cites this paper
• Proteases and Fibrosis

  2011cites this paper
• Editorial Manager(tm) for PLoS ONE Manuscript Draft Manuscript Number: PONE-D-10-05386R2 Title: Extracellular Heat Shock Protein (Hsp)70 and Hsp90α Assist in Matrix Metalloproteinase-2 Activation and Breast Cancer Cell Migration and Invasion Short Title: Hsp70 and Hsp90α Assist in MMP-2 Activation

  2011cites this paper
• The zebrafish as a model for tissue regeneration and bone remodelling

  2011cites this paper
• The mechanism of signal transduction by the GPI anchored Prod 1 protein

  2010cites this paper
• The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion

  2010cites this paper
• Protein targets of inflammatory serine proteases and cardiovascular disease

  2010cites this paper
• Alpha-lipoic acid inhibits thrombin-induced fetal membrane weakening in vitro.

  2010cites this paper
• Functional intersection of the kallikrein-related peptidases (KLKs) and thrombostasis axis

  2010cites this paper
• Thrombin-dependent MMP-2 Activity Is Regulated by Heparan Sulfate*

  2010cites this paper
• Hookworm (Necator americanus) larval enzymes disrupt human vascular endothelium.

  2010cites this paper
• Cancer and Coagulation; Focusing on Tissue Factor and Heparanase

  2010cites this paper
• The Indazole Derivative YD-3 Specifically Inhibits Thrombin-Induced Angiogenesis In Vitro and In Vivo

  2010cites this paper
• Experimental models in intracerebral hemorrhage.

  2009cites this paper
• Thrombin: To PAR or Not to PAR, and the Regulation of Inflammation

  2009cites this paper
• Receptor tyrosine kinase EphA2 mediates thrombin-induced upregulation of ICAM-1 in endothelial cells in vitro.

  2009cites this paper
• Effects of Inflammatory Mediators on Matrix Metalloproteinase-2 Expression by Rheumatoid Arthritis Synovial Fibroblasts

  2009cites this paper
• Analysis of alpha2-adrenergic receptors and effect of brimonidine on matrix metalloproteinases and their inhibitors in human ciliary body.

  2009cites this paper
• ADAM-17 regulates endothelial cell morphology, proliferation, and in vitro angiogenesis.

  2009cites this paper
• Regulatory Mechanism of Matrix Metalloprotease-2 Enzymatic Activity by Factor Xa and Thrombin*

  2009cites this paper
• Membrane type‐1 matrix metalloprotease‐independent activation of pro‐matrix metalloprotease‐2 by proprotein convertases

  2009cites this paper
• Thrombin stimulates mitogenesis in pig cerebrovascular smooth muscle cells involving activation of pro-matrix metalloproteinase-2.

  2009cites this paper
• Relative Importance of Proteinase-Activated Receptor-1 Versus Matrix Metalloproteinases in Intracerebral Hemorrhage-Mediated Neurotoxicity in Mice

  2009cites this paper
• Thrombin's central role in angiogenesis and pathophysiological processes.

  2009cites this paper
• Cocoa procyanidins inhibit expression and activation of MMP-2 in vascular smooth muscle cells by direct inhibition of MEK and MT1-MMP activities.

  2008cites this paper
• Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems

  2008cites this paper
• Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more

  2008cites this paper
• 2‐Chloroadenosine modulates PAR‐1 and IL‐23 expression and enhances docetaxel effects on PC3 cells

  2008cites this paper
• Wirkungen der Gerinnungsfaktoren Thrombin und Faktor-Xa auf vaskuläre Zellen des Menschen

  2008cites this paper
• KALLIKREIN-RELATED PEPTIDASE SIGNALLING VIA PROTEINASE-ACTIVATED RECEPTORS

  2008cites this paper
• Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead.

  2008cites this paper
• Impact of plasminogen on an in vitro wound healing model based on a perfusion cell culture system

  2008cites this paper
• In Situ Bioengineering of Arterial Vein Grafts

  2008influential citation
• 2-Chloroadenosine and human prostate cancer cells.

  2008cites this paper
• Proteinases as hormones: targets and mechanisms for proteolytic signaling

  2008cites this paper
• Can matrix metalloproteinase inhibitors provide a realistic therapy in cardiovascular medicine?

  2007cites this paper
• Expression profiles of the duplicated matrix metalloproteinase‐9 genes suggest their different roles in apoptosis of larval intestinal epithelial cells during Xenopus laevis metamorphosis

  2007cites this paper
• Local and systemic pathophysiological alterations induced by a serine proteinase from the venom of the snake Bothrops jararacussu.

  2007cites this paper
• Collagen I and thrombin activate MMP-2 by MMP-14-dependent and -independent pathways: implications for airway smooth muscle migration.

  2007cites this paper
• Cancer biomarker discovery via low molecular weight serum proteome profiling – Where is the tumor?

  2007cites this paper
• Proteinase-activated receptors in the lower urinary tract

  2007cites this paper
• ADAMTS1 i TFPI-2: Estudi de la seva interacció funcional i les implicacions en la plasticitat tumoral.

  2007cites this paper
• Thrombin‐induced cell proliferation and platelet‐derived growth factor‐AB release from A172 human glioblastoma cells

  2007cites this paper
• Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor‐suppressor efficacy

  2007influential citation
• Opposite effects of high glucose on MMP‐2 and TIMP‐2 in human endothelial cells

  2007influential citation
• Elastokines et angiogenése : rôle de la MT1-MMP et signalisation intracellulaire mediée par S-GAL

  2007cites this paper
• Angiopoietin-2 and platelet-derived growth-BB factor cooperatively affect peripheral blood monocyte fibrinolysis

  2007cites this paper
• Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP.

  2006cites this paper
• Natural history and treatment of bone complications in prostate cancer.

  2006cites this paper
• Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more

  2006cites this paper
• cAMP elevating agents suppress secretory phospholipase A(2)-induced matrix metalloproteinase-2 activation.

  2006cites this paper
• CombinationofThrombinandMatrixMetalloproteinase-9 ExacerbatesNeurotoxicityinCellCultureandIntracerebral HemorrhageinMice

  2006cites this paper
• Atherosclerosis and proteinase activation.

  2006cites this paper
• Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis

  2006cites this paper
• TIMP Independence of Matrix Metalloproteinase (MMP)-2 Activation by Membrane Type 2 (MT2)-MMP Is Determined by Contributions of Both the MT2-MMP Catalytic and Hemopexin C Domains*

  2006cites this paper
• Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2.

  2006cites this paper
• Combination of Thrombin and Matrix Metalloproteinase-9 Exacerbates Neurotoxicity in Cell Culture and Intracerebral Hemorrhage in Mice

  2006cites this paper
• Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells.

  2005cites this paper
• A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells.

  2005cites this paper
• Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.

  2005cites this paper
• Membrane type-matrix metalloproteinases and tumor progression.

  2005cites this paper
• Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants

  2005cites this paper
• Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.

  2005cites this paper
• Physiology and pathophysiology of proteinase-activated receptors (PARs): proteinases as hormone-like signal messengers: PARs and more.

  2005cites this paper
• Structure, function and biology of tissue factor pathway inhibitor-2

  2005cites this paper
• Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression.

  2005influential citation